Treatment Option Overview
Successful treatment generally requires the combination of effective systemic chemotherapy and complete resection of all clinically detectable disease. Protective weight bearing is recommended for patients with tumors of weight-bearing bones to prevent pathological fractures that could preclude limb-preserving surgery.
Randomized clinical trials have established that both neoadjuvant and adjuvant
chemotherapy are effective in preventing relapse in patients with clinically nonmetastatic tumors.[1,2] It is imperative that patients with proven or suspected
osteosarcoma have an initial evaluation by an orthopedic oncologist familiar
with the surgical management of this disease. This evaluation, which includes imaging studies, should be done
prior to the initial biopsy, since an inappropriately performed biopsy may
jeopardize a limb-sparing procedure.
The designations in PDQ that treatments are “standard” or “under clinical
evaluation” are not to be used as a basis for reimbursement determinations.
References
-
Eilber F, Giuliano A, Eckardt J, et al.: Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol 5 (1): 21-6, 1987.
[PUBMED Abstract]
-
Link MP, Goorin AM, Miser AW, et al.: The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314 (25): 1600-6, 1986.
[PUBMED Abstract]
Back to Top
< Previous Section | Next Section > |